-
February 13, 2013
AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma, Inc. (ALPMY) recently announced final overall survival (OS) ...
-
February 11, 2013
The US Food and Drug Administration (FDA) recently delivered encouraging news to Celgene Corporation (CELG) by ...
-
January 22, 2013
Amgen (AMGN) is scheduled to report its fourth quarter 2012 results on Jan 23, 2013 after the closing bell. Last ...
-
January 18, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently announced its intention to raise funds through the issuance of 4.4 ...
-
January 11, 2013
Infinity Pharmaceuticals Inc. (INFI) recently provided an update on its pipeline and issued its guidance for 2013. ...
-
January 09, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently provided an update on its performance in 2012 and its plans for 2013. ...
-
January 04, 2013
The HealthCare unit of Bayer (BAYRY) recently announced that a phase III trial (DECISION: n=417) of Nexavar ...
-
December 28, 2012
Bayer Yakuhin Ltd., the Japanese subsidiary of Bayer AG (BAYRY), submitted a marketing authorization application for ...
-
December 28, 2012
Biotech stocks have been major outpeformers in 2012.
-
December 26, 2012
We are reverting to a Neutral recommendation on Bayer (BAYRY) as we believe that all the positive news that led to ...
-
December 05, 2012
We are upgrading Onyx Pharmaceuticals (ONXX) to Outperform based on the company's strong third quarter results and ...
-
November 15, 2012
The market is currently down, with the Nasdaq falling 0.4%, the S&P 500 decreasing 0.3% and the Dow declining 0.3%. ...
-
November 14, 2012
The market is having a bad day so far. The Nasdaq has decreased 0.4%; the S&P 500 has fallen 0.5%; and the Dow is ...
-
November 14, 2012
The market is having a bad day so far: the Nasdaq is trading down 0.4%; the S&P 500 has fallen 0.5%; and the Dow has ...
-
November 13, 2012
The European Commission (EC) recently approved Swiss pharmaceutical giant Novartis' (NVS) Votubia to treat adults ...
-
November 09, 2012
This morning has been good for the market, with the Nasdaq moving up 0.9%, the S&P 500 rising 0.5% and the Dow ...
-
November 09, 2012
The Nasdaq has risen 0.9%, the S&P 500 has moved up 0.5% and the Dow is trading up 0.2%, marking a bad morning for ...
-
November 06, 2012
Onyx Pharmaceuticals Inc. (ONXX) reported a loss of 89 cents per share in the third quarter of 2012, narrower than ...
-
November 02, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has decreased 0.2% and the Dow has declined 0.3% after the ...
-
October 31, 2012
Recently, the HealthCare unit of Bayer (BAYRY) announced that its oncology drug Stivarga (regorafenib) will be ...
